DEA Document Epilepsy Packaging 
The Joint Blog
SEPTEMBER 19, 2019
Food and Drug Administration has approved one CBD-based medicine for treating seizures associated with two rare and severe forms of epilepsy but says it cannot be added to food, drinks or dietary supplements. The packaging doesn’t identify the companies and their brands have little online presence. and New Zealand.
CannaMD
SEPTEMBER 15, 2020
Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Any other documentation that provides proof of residential address as determined by department rule. SHORT ANSWER: Yes, but products must be contained in their original packaging.
Cannabis Law Report
JULY 12, 2019
This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. References. 1Alexandra L.
Expert insights. Personalized for you.
44 
Let's personalize your content